Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data

BACKGROUND: Erythropoiesis‐stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might increase mortality. OBJECTIVES: Our objectives were to examine the effect of ESAs and identify factors that modify the effects of ESAs on over...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Bohlius, Julia, Schmidlin, Kurt, Brillant, Corinne, Schwarzer, Guido, Trelle, Sven, Seidenfeld, Jerome, Zwahlen, Marcel, Clarke, Mike J, Weingart, Olaf, Kluge, Sabine, Piper, Margaret, Napoli, Maryann, Rades, Dirk, Steensma, David, Djulbegovic, Benjamin, Fey, Martin F, Ray‐Coquard, Isabelle, Moebus, Volker, Thomas, Gillian, Untch, Michael, Schumacher, Martin, Egger, Matthias, Engert, Andreas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2009
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208183/
https://ncbi.nlm.nih.gov/pubmed/19588423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007303.pub2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller